If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.
This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.
For important safety and use information, please see summary of product characteristics or country-specific prescribing information.
Safety Profile of Kovaltry
Kovaltry and Natural FVIII
Bayer in Hemophilia Tools & Resources Programs for Your Hemophilia Patients
© 2022 Bayer AG
This website is intended to provide information to an international audience outside the USA and UK
Last updated: June 2022